Brought to you by 
Phoqus Pharmaceuticals nets £9mm in IPO
21 Nov 2005
Executive Summary
Drug delivery technology company Phoqus Pharmaceuticals Ltd., a 1998 spin-out of Berwind Pharmaceutical, has netted £9mm ($16mm) in its initial public offering on London's AIM. It sold 7.14mm new ordinary shares at 140 pence ($2.48) each.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Phoqus Pharmaceuticals nets £9mm in IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice